Press Releases
Pfizer awards more than $1 million to fund metastatic...
Pfizer Inc announced that it has awarded a total of more than $1 million in funding to five leading breast cancer advocacy organizations to support...
Press Releases
Johnson & Johnson opens first international JLABs site in...
Johnson & Johnson Innovation LLC announced the opening of JLABS @ Toronto, a new 40,000-square-foot life sciences incubator, providing entrepreneurs shared lab space and offices,...
Press Releases
Merck Showcases New Innovations at Analytica 2016
Merck, a leading science and technology company, will exhibit a new range of products and solutions at Analytica 2016, the international trade fair for laboratory...
Press Releases
Baxter to Present at the 2016 UBS Global Healthcare...
Baxter International Inc will present at the 2016 UBS Global Healthcare Conference on Monday, May 23 in New York, NY. Jay Saccaro, corporate vice president...
Press Releases
US FDA Expands IMBRUVICA (ibrutinib) Label to Include Overall...
AbbVie a global biopharmaceutical company announced the U.S. Food and Drug Administration (FDA) updated the IMBRUVICA® (ibrutinib) Prescribing Information (PI) to include new data from...
Press Releases
Merck Launches First Commercially Available Equine-Specific Multiplex Assay for...
Merck, a leading science and technology company, today announced the global launch of the first commercially-available equine-specific multiplex assay for protein biomarkers. The assay is...
Press Releases
Allergan and Richter Announce Positive Phase III Results for...
Phase III study met all co-primary and secondary endpoints and achieved statistically significant resultsWorld pharma today/-press releases/-Allergan Plc and Gedeon Richter Plc. announced positive results...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.